WLK
Westlake CorpPrice & Indicators
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| EBITDA non-GAAP | $235M | Q1 2026 call | — |
| EBITDA uplift from profitability improvement plan non-GAAP | $150M | Q1 2026 call | — |
| HIP EBITDA non-GAAP | $186M | Q1 2026 call | — |
| PEM EBITDA non-GAAP | $36M | Q1 2026 call | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Specialty Chemicals — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
WLK
this stock
Westlake Corp
|
$9.67B | +2.6% | -20.6% | — | 3.8% |
|
LIN
Linde PLC
|
$245.08B | +24.7% | +3.0% | 35.1 | 1.4% |
|
AIQUF
L Air Liquide SA /Fi
|
$124.05B | +5.5% | — | — | 0.0% |
|
SHW
Sherwin Williams Co
|
$82.37B | +3.0% | +26.4% | 32.1 | 3.2% |
|
ECL
Ecolab Inc.
|
$77.34B | +4.8% | +2.2% | 37.2 | 1.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| WLK | +1.0% | -13.4% | -14.1% | +3.4% | +2.6% |
| SPY | +0.8% | +2.0% | +8.9% | +0.7% | +10.2% |
| vs SPY | +0.2% | -15.3% | -23.0% | +2.8% | -7.6% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.